Last reviewed · How we verify
Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol
Primary Objective: • To assess the possible utility of topical timolol in the management of port-wine mark (PWM) in Sturge-Weber syndrome in children.
Details
| Lead sponsor | Wills Eye |
|---|---|
| Phase | Phase 1 |
| Status | TERMINATED |
| Enrolment | 3 |
| Start date | 2012-02 |
| Completion | 2019-02 |
Conditions
- Sturge Weber Syndrome
- Port-wine Mark
Interventions
- Timolol
- Preservative free artificial tear gel.
Primary outcomes
- Appearance of Port-wine Mark at treatment site — 12 months
Changes of color and size of PWM at treatment site will determine efficacy of the topical timolol.
Countries
United States